Indication
Postencephalitic parkinsonism
Postencephalitic parkinsonism is a secondary form of parkinsonism that develops as a delayed neurodegenerative sequela following a viral central nervous system infection, historically most prominent among survivors of encephalitis lethargica. Read more about Postencephalitic parkinsonism
165 drugs 110 manufacturers
Drugs that treat it
Common Postencephalitic parkinsonism therapies.
AMANTADINE (amantadine HCl)
BENZTROPINE MESYLATE
CARBIDOPA-LEVODOPA (carbidopa/levodopa)
CARBIDOPA
BENZTROPINE MESYLATE
CARBIDOPA-LEVODOPA (carbidopa/levodopa)
AMANTADINE (amantadine HCl)
CARBIDOPA-LEVODOPA (carbidopa/levodopa)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPostencephalitic parkinsonism is a secondary form of parkinsonism that develops as a delayed neurodegenerative sequela following a viral central nervous system infection, historically most prominent among survivors of encephalitis lethargica.
The condition primarily impacts the extrapyramidal motor system through the progressive loss of dopaminergic neurons within the substantia nigra and midbrain networks.
Clinically, affected individuals exhibit classic features such as bradykinesia, muscular rigidity, postural instability, and tremors, frequently accompanied by distinctive manifestations like oculogyric crises, cranial neuropathies, and behavioral disturbances.
Pathophysiologically, it is characterized by neurofibrillary tangles and tau pathology in the basal ganglia and brainstem in the absence of the Lewy bodies and alpha-synuclein aggregates typically observed in idiopathic Parkinson disease.
- nih.gov
Postencephalitic parkinsonism is a secondary form of parkinsonism that develops as a delayed neurodegenerative sequela following a viral central nervous system infection, historically most prominent among survivors of encephalitis lethargica Clinically, affected individuals exhibit classic features such as bradykinesia, muscular rigidity, postural instability, and tremors, frequently accompanied by distinctive manifestations like oculogyric crises, cranial neuropathies, and behavioral disturbanc...
- britannica.com
Postencephalitic parkinsonism is a secondary form of parkinsonism that develops as a delayed neurodegenerative sequela following a viral central nervous system infection, historically most prominent among survivors of encephalitis lethargica
- nih.gov
The condition primarily impacts the extrapyramidal motor system through the progressive loss of dopaminergic neurons within the substantia nigra and midbrain networks Clinically, affected individuals exhibit classic features such as bradykinesia, muscular rigidity, postural instability, and tremors, frequently accompanied by distinctive manifestations like oculogyric crises, cranial neuropathies, and behavioral disturbances Pathophysiologically, it is characterized by neurofibrillary tangles and...
- nih.gov
The condition primarily impacts the extrapyramidal motor system through the progressive loss of dopaminergic neurons within the substantia nigra and midbrain networks Pathophysiologically, it is characterized by neurofibrillary tangles and tau pathology in the basal ganglia and brainstem in the absence of the Lewy bodies and alpha-synuclein aggregates typically observed in idiopathic Parkinson disease
- nih.gov
Clinically, affected individuals exhibit classic features such as bradykinesia, muscular rigidity, postural instability, and tremors, frequently accompanied by distinctive manifestations like oculogyric crises, cranial neuropathies, and behavioral disturbances
- wikipedia.org
Pathophysiologically, it is characterized by neurofibrillary tangles and tau pathology in the basal ganglia and brainstem in the absence of the Lewy bodies and alpha-synuclein aggregates typically observed in idiopathic Parkinson disease
Personalize your experience
Follow Postencephalitic parkinsonism and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.